Speculative stem cell futures: Some prospective commercial models for induced pluripotent stem (iPS) cell based therapies

Journal of Futures Studies

Volumn 14, Issue 4, 2010, Pages 85-96

  Harvey, Olivia ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bioeconomies; Biopolitics; Commercial models; Stem cells

Indexed keywords

EID: 77956787858     PISSN: 10276084     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Advanced Cell Technology. (2009). Advanced cell technology files IND with FDA for first human clinical trial using embryonic stem cells to treat eye disease. Press Release. Retrieved February 9, 2010, from http://www.advancedcell.com/press-release/advanced-cell-technology-files-ind-with-fda-for-first-human-clinical-trial-usingembryonic-stem-cells-to-treat-eye-disease
2. Blow, Nathan. (February, 2008). A new path to pluripotency, Nature, 451(14), 858.
3. Cormick, Craig. (2007). What does the public really think and who do they really trust? In M. Stranger. (Ed.), Human biotechnology and public trust: Trends, perceptions and regulations. Hobart, Australia: Centre for Law and Genetics.
4. Critchley, Christine, & Lyn Turney. (2004). Understanding Australian's perceptions of controversial scientific research. Australian Journal of Emerging Technologies and Society, 2.
5. Critchely, Christine. (2007). Stem cell research: What do the Australian public really think and why? In Stranger, M. (Ed.) Human biotechnology and public trust: Trends, perceptions and regulations. Hobart, Australia: Centre for Law and Genetics.
6. DNA Art. (2010). Company website. Retrieved February 8, 2010, from http://www.dnaart.com.au
7. Downey, Robin, & Rose Geransar. (2008). Stem cell research, publics' and stakeholder views, Health Law Review, 16(2), 69-85.
8. Ganchoff, Chris. (2004). Regenerative movements: Embryonic stem cells and the politics of potentiality, Sociology of Health and Illness, 26(6), 757-774.
9. Geron Corporation. (2008). Presentation at NSW Stem Cell Network Meeting, Sydney, August 21.
10. Gottweis, Herbert, Brian Salter, & Catherine Waldby. (2009). The global politics of human embryonic stem cell research: Regenerative medicine in transition. Basingstoke, UK: Palgrave Macmillan.
11. Haran, Joan, Jenny Kitzinger, Maureen O'Neill, & Kate O'Riordan. (2008). Human cloning in the media: From science fiction to science practice. New York: Routledge.
12. Harvey, Olivia. (2010b). Beyond technology and nature: Some historical and sociological reflections on the relationship between humans and machines. Berlin, Germany: VDM Verlag.
13. Humphries, Courtney. (2009, June 17). A stem cell therapy for blindness. Technology Review, Retrieved February 9, 2010, from http://www.technologyreview.com/biomedicine/22871/page1/
14. Lau, Darren, Ugbaka Ogbugu, Benjamin Taylor, Tania Stafinski, Devidas Menon, & Timothy Caulfield. (December, 2008). Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine, Cell Stem Cell, 3(4), 591-594.
15. Martin, Paul, Catherine Coveney, Alison Kraft, Nik Brown, & Philip Bath. (2006). Commercial development of stem cell technology: Lessons from the past, strategies for the future. Regenerative Medicine, 1(6), 801-807.
16. O'Riordan, Kate. (2008). Human cloning in film: Horror, ambivalence, hope. Science as Culture, 17(2), 145-162.
17. Prescott, Cathy. (2008). The promise of stem cells: A venture capital perspective. In Polack, Julia, Sakis Mantalaris, & Sian Harding. (Eds.), Advances in tissue engineering. London: Imperial College.
18. Perrin, Nicola. (2005). The global commercialisation of UK stem cell research, Department of Trade and Investment, UK. Retrieved February 8, 2010, from http://chrismason. com/industry_library/assets/UKTI%20Stem%20Cell%20Res.pdf
19. Ryan, Kristen A., Amanda N. Sanders, Dong D. Wang, & Aaron D. Levine. (2010). Tracking the rise of stem cell tourism? Regenerative Medicine, 5(1), 27-33.
20. Salter, Brian, Melinda Cooper, & Amanda Dickins. (2006) China and the global stem cell bioeconomy: An emerging political strategy? Regenerative Medicine, 1(5), 671-683.
21. Salter, Brian, Melinda Cooper, Amanda Dickins, & Valentina Cardo. (2007) Stem cell science in India: Emerging economies and the politics of globalisation. Regenerative Medicine, 2(1), 75-89.
22. Salter, Brian, & Olivia Harvey. (2008). Stem cell innovation in the United States: The benefit of the minimal state. Regenerative medicine, 3(4), 597-610.
23. Scheper-Hughes, Nancy. (2003). Rotten trade: Millennial capitalism, human values and global justice in organs trafficking. Journal of Human Rights, 2(2), 75-89.
24. Shelley, Mary. (1992[orig.1818]). Frankenstein: Or, the modern Prometheus. London: Penguin.
25. Sky News. (July 21, 2009). Man, 22, dies after liver transplant refused. Retrieved February 8, 2010, from http://news.sky.com/skynews/Home/UK-News/Alcoholic-22-Dies-After-Being-Refused-Life-Saving-Liver-Transplant/Article/200907315342299
26. Takahashi, Kazutoshi, & Shinya Yamanaka. (August, 2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures defined by factor. Cell, 126(25), 663-676.
27. Thomson, James A., Joseph Itskovitz-Eldor, Sander S. Shapiro, Michelle A. Waknitz, Jennifer J. Swiergiel, Vivienne, S. Marshal, & Jeffrey M. Jones. (November 6, 1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 115-1147.
28. Tissue Engineering and Regenerative Medicine Society (TERMIS). (2009). 2nd World Congress, Seoul, Republic of Korea, August 31-September 3.
29. Waldby, Catherine. (2006) Umbilical cord blood: From social gift to venture capital. BioSocieties, 1(1), 55-70.
30. Waldby, Catherine, & Robert Mitchell. (2006). Tissue economies: Blood, organs and cell lines in late capitalism. Durham: Duke University Press.
31. Whittaker, Andrea. (2009, September). Global technologies and transnational reproduction in Thailand. Asian Studies Review, 333, 19-332.
32. Yu, Junying, Maxim A. Vodyanik, Kim Smug-Otto, Jessica Antosiewicz-Bourget, Jennifer L. Frane, Shula Tian, Jeff Nie, Gudrun A. Jonsdottir, Victor Ruotti, Ron Stewart, Igor I. Slukvin, & James A. Thomson. (December 21, 2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.